Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1238
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study ; volume:40 ; number:6 ; day:16 ; month:4 ; year:2014 ; pages:830-838 ; date:6.2014
Intensive care medicine ; 40, Heft 6 (16.4.2014), 830-838, 6.2014
- Urheber
-
Karnad, Dilip R.
Bhadade, Rakesh
Verma, Pradeep K.
Moulick, Nivedita D.
Daga, Mradul K.
Chafekar, Neelima D.
Iyer, Shivakumar
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00134-014-3278-8
- URN
-
urn:nbn:de:101:1-2019102704564938191598
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karnad, Dilip R.
- Bhadade, Rakesh
- Verma, Pradeep K.
- Moulick, Nivedita D.
- Daga, Mradul K.
- Chafekar, Neelima D.
- Iyer, Shivakumar
- SpringerLink (Online service)
Ähnliche Objekte (12)
Characterization of Purified Urinary Trypsin Inhibitors
Trypsin-Inhibitor
Immunological effects of intravenous selenium administration in severe sepsis
Trypsin-Ampullen (Spofa)
Patients knowledge and experience with urinary and peripheral intravenous catheters
KMR-spektroskopische Untersuchung von Trypsininhibitoren, Trypsin und Trypsin-Trypsininhibitor-Komplexen
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
Trypsin- und Chymotrypsininhibitoren in Kartoffeln
Incidence and risk factors of urinary tract infection in neonatal sepsis
Efficacy of single-dose intravenous immunoglobulin administration for severe sepsis and septic shock
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
Maintenance intravenous fluid therapy in infants with sepsis and hyponatremia: a clinical trial
Characterization of Purified Urinary Trypsin Inhibitors
Trypsin-Inhibitor
Immunological effects of intravenous selenium administration in severe sepsis
Trypsin-Ampullen (Spofa)
Patients knowledge and experience with urinary and peripheral intravenous catheters
KMR-spektroskopische Untersuchung von Trypsininhibitoren, Trypsin und Trypsin-Trypsininhibitor-Komplexen
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
Trypsin- und Chymotrypsininhibitoren in Kartoffeln
Incidence and risk factors of urinary tract infection in neonatal sepsis
Efficacy of single-dose intravenous immunoglobulin administration for severe sepsis and septic shock
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
Maintenance intravenous fluid therapy in infants with sepsis and hyponatremia: a clinical trial
Characterization of Purified Urinary Trypsin Inhibitors
Trypsin-Inhibitor
Immunological effects of intravenous selenium administration in severe sepsis
Trypsin-Ampullen (Spofa)
Patients knowledge and experience with urinary and peripheral intravenous catheters
KMR-spektroskopische Untersuchung von Trypsininhibitoren, Trypsin und Trypsin-Trypsininhibitor-Komplexen
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
Trypsin- und Chymotrypsininhibitoren in Kartoffeln
Incidence and risk factors of urinary tract infection in neonatal sepsis
Efficacy of single-dose intravenous immunoglobulin administration for severe sepsis and septic shock
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis